PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.07%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-15.51%
Negative gross profit growth while OBE is at 18.27%. Joel Greenblatt would examine cost competitiveness or demand decline.
-37.21%
Negative EBIT growth while OBE is at 1045.45%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-37.21%
Negative operating income growth while OBE is at 16.79%. Joel Greenblatt would press for urgent turnaround measures.
133.62%
Net income growth at 50-75% of OBE's 248.96%. Martin Whitman would question fundamental disadvantages in expenses or demand.
131.25%
EPS growth at 50-75% of OBE's 248.18%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
131.25%
Diluted EPS growth at 50-75% of OBE's 248.18%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.96%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-18.66%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-52.08%
Negative FCF growth while OBE is at 448.15%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-27.47%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-57.22%
Negative 5Y CAGR while OBE stands at 17.34%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-20.55%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
19.51%
OCF/share CAGR of 19.51% while OBE is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-60.24%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-20.86%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
34.57%
Positive 10Y CAGR while OBE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
14.92%
Below 50% of OBE's 391.12%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
53.00%
Positive short-term CAGR while OBE is negative. John Neff would see a clear advantage in near-term profit trajectory.
-25.90%
Negative equity/share CAGR over 10 years while OBE stands at 23.73%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-71.54%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-60.18%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
34.87%
Dividend/share CAGR of 34.87% while OBE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-83.16%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-66.20%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-3.69%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-4.28%
Inventory is declining while OBE stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
8.90%
Positive asset growth while OBE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
32.38%
Positive BV/share change while OBE is negative. John Neff sees a clear edge over a competitor losing equity.
-1.51%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
3.53%
We expand SG&A while OBE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.